Name: | adenylate cyclase (AC) |
Definition: | Signal transduction through the cell membrane requires the participation of one or more plasma membrane proteins. For many transmembrane signaling events adenylyl cyclases (ACs) are the final effector enzymes which integrate and interpret divergent signals from different pathways. The enzymatic activity of adenylyl cyclases is stimulated or inhibited in response to the activation of a large number of receptors in virtually all cells of the human body. To date, ten different mammalian isoforms of adenylyl cyclase (AC) have been cloned and characterized. Each isoform has its own distinct tissue distribution and regulatory properties, providing possibilities for different cells to respond diversely to similar stimuli. The product of the enzymatic reaction catalyzed by ACs, cyclic AMP (cAMP) has been shown to play a crucial role for a variety of fundamental physiological cell functions ranging from cell growth and differentiation, to transcriptional regulation and apoptosis. |
Category ID: | P04450 |
Synonyms: | |
Upstream: | |
Downstream: | |
Number Families/Subfamilies: | 2 |
Number of Associated Sequences: | 13 |
GO Molecular Function: |
-
|
GO Biological Process: |
-
|
GO Cellular Component: |
-
|
PANTHER protein class: |
-
|
References: | Medline:11376933 |
Sequence Association
Panther Subfamily | Associated Sequence | Definition | Confidence Code | Evidence |
PTHR45627:SF6 | A0A1D5RHE7 | Adenylate cyclase type 2 | ISS | PubMed:12472880 |
A0A1D5RHE7 | Adenylate cyclase type 2 | ISS | PubMed:15189569 | |
A0A1D5RHE7 | Adenylate cyclase type 2 | ISS | PubMed:1719547 | |
A0A1D5RHE7 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
F1MJV4 | Adenylate cyclase type 2 | ISS | PubMed:12472880 | |
F1MJV4 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
F6V001 | Adenylate cyclase type 2 | ISS | PubMed:12472880 | |
F6V001 | Adenylate cyclase type 2 | ISS | PubMed:15189569 | |
F6V001 | Adenylate cyclase type 2 | ISS | PubMed:1719547 | |
F6V001 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
F6ZAV4 | Adenylate cyclase type 2 | ISS | PubMed:12472880 | |
F6ZAV4 | Adenylate cyclase type 2 | ISS | PubMed:15189569 | |
F6ZAV4 | Adenylate cyclase type 2 | ISS | PubMed:1719547 | |
F6ZAV4 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
P26769 | Adenylate cyclase type 2 | ISS | PubMed:12472880 | |
P26769 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
Q08462 | Adenylate cyclase type 2 | ISS | PubMed:12472880 | |
Q08462 | Adenylate cyclase type 2 | ISS | PubMed:15189569 | |
Q08462 | Adenylate cyclase type 2 | ISS | PubMed:1719547 | |
Q08462 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
Q80TL1 | Adenylate cyclase type 2 | ISS | PubMed:12472880 | |
Q80TL1 | Adenylate cyclase type 2 | ISS | PubMed:15189569 | |
Q80TL1 | Adenylate cyclase type 2 | ISS | PubMed:1719547 | |
Q80TL1 | Adenylate cyclase type 2 | ISS | PubMed:2491850 | |
PTHR45627:SF9 | A0A5F8ADK4 | Adenylate cyclase type 7 | ISS | PubMed:11665607 |
A0A5F8ADK4 | Adenylate cyclase type 7 | ISS | PubMed:15581358 | |
A0A5F8ADK4 | Adenylate cyclase type 7 | ISS | PubMed:2491850 | |
F1LQT1 | Adenylate cyclase type 7 | ISS | PubMed:15581358 | |
F1LQT1 | Adenylate cyclase type 7 | ISS | PubMed:2491850 | |
K7ADQ0 | Adenylate cyclase type 7 | ISS | PubMed:11665607 | |
K7ADQ0 | Adenylate cyclase type 7 | ISS | PubMed:15581358 | |
K7ADQ0 | Adenylate cyclase type 7 | ISS | PubMed:2491850 | |
P51828 | Adenylate cyclase type 7 | ISS | PubMed:11665607 | |
P51828 | Adenylate cyclase type 7 | ISS | PubMed:15581358 | |
P51828 | Adenylate cyclase type 7 | ISS | PubMed:2491850 | |
P51829 | Adenylate cyclase type 7 | ISS | PubMed:15581358 | |
P51829 | Adenylate cyclase type 7 | ISS | PubMed:2491850 | |
Q29450 | Adenylate cyclase type 7 | ISS | PubMed:15581358 | |
Q29450 | Adenylate cyclase type 7 | ISS | PubMed:2491850 | |
Q29450 | Adenylate cyclase type 7 | ISS | PubMed:8557110 | |
Q29450 | Adenylate cyclase type 7 | ISS | PubMed:96149441 |